Alembic Pharma — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Alembic Pharma holds 69.87% of the company. At a market capitalisation of ₹15.78k cr, that holding is worth ₹11.03k cr.

Promoter stake

69.87%

Value of holding

₹11.03k cr

Market cap

₹15.78k cr

Stake change

+0.39%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q3-2021
69.48%—
Q4-2021
69.48%—
Q1-2022
69.61%—
Q2-2022
69.61%—
Q3-2022
69.61%—
Q4-2022
69.61%—
Q1-2023
69.61%—
Q2-2023
69.61%—
Q3-2023
69.61%—
Q4-2023
69.61%—
Q1-2024
69.61%—
Q2-2024
69.61%—
Q3-2024
69.61%—
Q4-2024
69.61%—
Q1-2025
69.67%—
Q2-2025
69.67%—
Q3-2025
69.74%—
Q4-2025
69.74%—
Q1-2026
69.74%—
Q2-2026
69.87%—
Q3-2026
69.87%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Alembic Pharma's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.